TheraB Medical

TheraB Medical is revolutionizing the treatment of neonatal jaundice with its flagship product, SnugLit. Operating in the healthcare sector, TheraB Medical targets hospitals, clinics, and home care settings, providing a holistic approach to jaundice phototherapy that emphasizes maternal-infant bonding, breastfeeding, and family togetherness. The SnugLit device offers 360-degree phototherapy coverage in a wearable format, allowing babies to receive necessary treatment while remaining in the arms of their parents. This approach not only enhances the emotional well-being of both the infant and the parents but also aims to improve treatment outcomes and patient satisfaction. TheraB Medical's business model involves direct sales to healthcare providers and consumers, as well as potential partnerships with medical institutions. Revenue is generated through the sale of SnugLit devices and potential future service offerings. The company is committed to disrupting traditional jaundice treatment methods and bringing innovative solutions to the market.

Keywords: neonatal jaundice, phototherapy, maternal bonding, wearable device, healthcare innovation, family togetherness, SnugLit, holistic treatment, patient satisfaction, medical devices.